US Patent Issued to The McLean Hospital on March 24 for "Autologous cell replacement therapy for Parkinson's disease" (Massachusetts Inventor)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,105, issued on March 24, was assigned to The McLean Hospital Corp. (Belmont, Mass.).

"Autologous cell replacement therapy for Parkinson's disease" was invented by Kwang-Soo Kim (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for generating midbrain dopamine (mDA) neuronal progenitor cells useful for autologous cell therapy in Parkinson's Disease, compositions comprising the cells, and methods of use thereof."

The patent was filed on May 21, 2020, under Application No. 17/613,586.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p...